VILPOWER M 1000 TAB

About

VILPOWER M 1000 TAB is a combination medication containing Vildagliptin and Metformin, used for the management of type 2 diabetes mellitus. Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that works by enhancing the body's natural ability to control blood glucose levels. It increases the levels of active incretin hormones, GLP-1 and GIP, which stimulate insulin secretion and suppress glucagon secretion in a glucose-dependent manner. Metformin, a biguanide, primarily reduces hepatic glucose production, decreases intestinal glucose absorption, and improves insulin sensitivity in peripheral tissues. This synergistic action provides a comprehensive approach to managing hyperglycemia, leading to significant reductions in HbA1c levels. It is typically prescribed as an adjunct to diet and exercise when monotherapy is insufficient.

Uses

• Management of type 2 diabetes mellitus
• Improvement of glycemic control
• Adjunct to diet and exercise
• Monotherapy or combination therapy

Directions For Use

Take orally with meals, usually once or twice daily, as directed by your physician.

Benefits

• Significant reduction in HbA1c levels
• Improved insulin sensitivity
• Reduced hepatic glucose production
• Low risk of hypoglycemia (Vildagliptin component)
• Potential for modest weight loss (Metformin component)
• Convenient fixed-dose combination therapy

Side Effects

• Nausea
• Diarrhea
• Abdominal pain
• Headache
• Dizziness
• Nasopharyngitis
• Tremor
• Hypoglycemia (rare)
• Lactic acidosis (rare, serious)
• Pancreatitis (rare)
• Skin reactions
• Vitamin B12 deficiency (long-term Metformin)

Safety Measures

• Alcohol - Avoid excessive alcohol consumption due to an increased risk of lactic acidosis, especially with the Metformin component.
• Pregnancy - Generally not recommended during pregnancy; consult your doctor. Insulin is often preferred for glycemic control in pregnant women.
• Breastfeeding - Not recommended during breastfeeding; consult your doctor. Metformin is known to pass into breast milk.
• Liver - Use with caution in patients with liver conditions. Metformin is contraindicated in severe hepatic impairment.
• Kidney - Dose adjustment is required in patients with renal impairment. Metformin is contraindicated in severe renal impairment.
• Lung - Use with caution in patients with severe respiratory conditions due to the potential for lactic acidosis.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.